GRI Bio, Inc.
GRI Bio, Inc. (GRI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GRI · as of Jun 8, 2026
Key Statistics
Explore GRI Bio, Inc. Data
gri stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
gri competitorsGRI
ABP
BDRX
CANF
CLDI
CNSPStock Performance
Full HistoryAbout GRI Bio, Inc.
GRI Bio, Inc. a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune diso…
what is gri bio, inc. · gri stock overview · gri bio, inc. company profile · who is gri bio, inc. ceo · gri NASDAQ · gri bio, inc. headquarters · gri bio, inc. business segments
About Stock Overview & Key Data
GRI Bio, Inc. (GRI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 24, 2023. As of the latest trading session, GRI stock price is $2.22, with a market capitalization of $199,427. The stock has returned -93.90% over the past 12 months and -67.87% year-to-date.
According to 2 Wall Street analysts, the consensus rating for GRI Bio, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, GRI Bio, Inc. reported revenue of — and net income of -$12.0M. For detailed data — including GRI Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GRI Bio, Inc. (GRI) stock price is $2.22. The stock is traded on NASDAQ under the ticker symbol GRI. The 52-week range is $1.97 – $80.36.